Nation's largest Pharmacy Benefits Manager accused of gaming its drug formulary and withholding billions in rebates from PBM customers.

Beactica Therapeutics AB, a Swedish precision medicine company, today announced that it, together with leading glioblastoma researchers at KU Leuven, has been awarded a EUR 2.5 million grant by the ...

Cardiovascular portfolio up 11% year-over-year; Cardiac Ablation Solutions grew 80% on strength of pulsed field ablation portfolio ...

Genmab anticipates its 2026 operating expenses to be in the range of $2.7 - 2.9 billion, compared to $2.2 billion in 2025. The increase in operating expenses is primarily related to investments in ...